<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>alosetron</title><link>http://www.unboundmedicine.com/medline/ebm/research/alosetron</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Gateways to clinical trials.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19798455/full_citation/Gateways_to_clinical_trials_</link><description>Tomillero A, Moral MA <br/><span class="title">Gateways to clinical trials. [Journal Article]</span><br/><span class="source" title="Methods and findings in experimental and clinical pharmacology">Methods Find Exp Clin Pharmacol 2009 Jul-Aug; 31(6):397-417.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19798455/abstract/Gateways_to_clinical_trials_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19798455/full_citation/Gateways_to_clinical_trials_">Full Citation</a></description></item><item><title>Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19785647/full_citation/Alosetron_cilansetron_and_tegaserod_modify_mesenteric_but_not_colonic_blood_flow_in_rats_</link><description>Painsipp E, Shahbazian A, Holzer P <br/><span class="title">Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of pharmacology">Br J Pharmacol 2009 Sep 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19785647/abstract/Alosetron_cilansetron_and_tegaserod_modify_mesenteric_but_not_colonic_blood_flow_in_rats_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19785647/full_citation/Alosetron_cilansetron_and_tegaserod_modify_mesenteric_but_not_colonic_blood_flow_in_rats_">Full Citation</a></description></item><item><title>Using the Incremental Net Benefit Framework for Quantitative Benefit-Risk Analysis in Regulatory Decision-Making-A Case Study of Alosetron in Irritable Bowel Syndrome.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19744297/full_citation/Using_the_Incremental_Net_Benefit_Framework_for_Quantitative_Benefit_Risk_Analysis_in_Regulatory_Decision_Making_A_Case_Study_of_Alosetron_in_Irritable_Bowel_Syndrome_</link><description>Lynd LD, Najafzadeh M, Colley L, et al. <br/><span class="title">Using the Incremental Net Benefit Framework for Quantitative Benefit-Risk Analysis in Regulatory Decision-Making-A Case Study of Alosetron in Irritable Bowel Syndrome. [JOURNAL ARTICLE]</span><br/><span class="source" title="Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research">Value Health 2009 Sep 10.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19744297/abstract/Using_the_Incremental_Net_Benefit_Framework_for_Quantitative_Benefit_Risk_Analysis_in_Regulatory_Decision_Making_A_Case_Study_of_Alosetron_in_Irritable_Bowel_Syndrome_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19744297/full_citation/Using_the_Incremental_Net_Benefit_Framework_for_Quantitative_Benefit_Risk_Analysis_in_Regulatory_Decision_Making_A_Case_Study_of_Alosetron_in_Irritable_Bowel_Syndrome_">Full Citation</a></description></item><item><title>Genetics and Irritable Bowel Syndrome: From Genomics to Intermediate Phenotype and Pharmacogenetics.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19655247/full_citation/Genetics_and_Irritable_Bowel_Syndrome:_From_Genomics_to_Intermediate_Phenotype_and_Pharmacogenetics_</link><description>Camilleri M <br/><span class="title">Genetics and Irritable Bowel Syndrome: From Genomics to Intermediate Phenotype and Pharmacogenetics. [JOURNAL ARTICLE]</span><br/><span class="source" title="Digestive diseases and sciences">Dig Dis Sci 2009 Aug 5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19655247/abstract/Genetics_and_Irritable_Bowel_Syndrome:_From_Genomics_to_Intermediate_Phenotype_and_Pharmacogenetics_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19655247/full_citation/Genetics_and_Irritable_Bowel_Syndrome:_From_Genomics_to_Intermediate_Phenotype_and_Pharmacogenetics_">Full Citation</a> | <a href="http://dx.doi.org/10.1007/s10620-009-0903-4">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19655247/Genetics_and_Irritable_Bowel_Syndrome:_From_Genomics_to_Intermediate_Phenotype_and_Pharmacogenetics_">Find Related Articles</a> </description></item><item><title>Pathogenesis and management of irritable bowel syndrome.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19624083/full_citation/Pathogenesis_and_management_of_irritable_bowel_syndrome_</link><description>Mathew P, Bhatia SJ <br/><span class="title">Pathogenesis and management of irritable bowel syndrome. [Journal Article]</span><br/><span class="source" title="Tropical gastroenterology : official journal of the Digestive Diseases Foundation">Trop Gastroenterol 2009 Jan-Mar; 30(1):19-25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19624083/abstract/Pathogenesis_and_management_of_irritable_bowel_syndrome_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19624083/full_citation/Pathogenesis_and_management_of_irritable_bowel_syndrome_">Full Citation</a></description></item><item><title>Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19585728/full_citation/Irritable_bowel_syndrome:_a_mild_disorder;_purely_symptomatic_treatment_</link><description><span class="title">Irritable bowel syndrome: a mild disorder; purely symptomatic treatment. [Journal Article]</span><br/><span class="source" title="Prescrire international">Prescrire Int 2009 Apr; 18(100):75-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19585728/abstract/Irritable_bowel_syndrome:_a_mild_disorder;_purely_symptomatic_treatment_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19585728/full_citation/Irritable_bowel_syndrome:_a_mild_disorder;_purely_symptomatic_treatment_">Full Citation</a></description></item><item><title>Efficacy of 5-HT(3) Antagonists and 5-HT(4) Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19471254/full_citation/Efficacy_of_5_HT_3__Antagonists_and_5_HT_4__Agonists_in_Irritable_Bowel_Syndrome:_Systematic_Review_and_Meta_Analysis_</link><description>Ford AC, Brandt LJ, Young C, et al. <br/><span class="title">Efficacy of 5-HT(3) Antagonists and 5-HT(4) Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. [JOURNAL ARTICLE]</span><br/><span class="source" title="The American journal of gastroenterology">Am J Gastroenterol 2009 May 26.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19471254/abstract/Efficacy_of_5_HT_3__Antagonists_and_5_HT_4__Agonists_in_Irritable_Bowel_Syndrome:_Systematic_Review_and_Meta_Analysis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19471254/full_citation/Efficacy_of_5_HT_3__Antagonists_and_5_HT_4__Agonists_in_Irritable_Bowel_Syndrome:_Systematic_Review_and_Meta_Analysis_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19471254/Efficacy_of_5_HT_3__Antagonists_and_5_HT_4__Agonists_in_Irritable_Bowel_Syndrome:_Systematic_Review_and_Meta_Analysis_">Find Related Articles</a> </description></item><item><title>Intracolonical administration of protease-activated receptor-2 agonists produced visceral hyperalgesia by up-regulating serotonin in the colon of rats.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19374846/full_citation/Intracolonical_administration_of_protease_activated_receptor_2_agonists_produced_visceral_hyperalgesia_by_up_regulating_serotonin_in_the_colon_of_rats_</link><description>Li Z, Zhang XJ, Xu HX, et al. <br/><span class="title">Intracolonical administration of protease-activated receptor-2 agonists produced visceral hyperalgesia by up-regulating serotonin in the colon of rats. [JOURNAL ARTICLE]</span><br/><span class="source" title="European journal of pharmacology">Eur J Pharmacol 2009 Jan 29.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19374846/abstract/Intracolonical_administration_of_protease_activated_receptor_2_agonists_produced_visceral_hyperalgesia_by_up_regulating_serotonin_in_the_colon_of_rats_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19374846/full_citation/Intracolonical_administration_of_protease_activated_receptor_2_agonists_produced_visceral_hyperalgesia_by_up_regulating_serotonin_in_the_colon_of_rats_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19374846/Intracolonical_administration_of_protease_activated_receptor_2_agonists_produced_visceral_hyperalgesia_by_up_regulating_serotonin_in_the_colon_of_rats_">Find Related Articles</a> </description></item><item><title>Role of serotonin in gastrointestinal motility and irritable bowel syndrome.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19361459/full_citation/Role_of_serotonin_in_gastrointestinal_motility_and_irritable_bowel_syndrome_</link><description>Sikander A, Rana SV, Prasad KK <br/><span class="title">Role of serotonin in gastrointestinal motility and irritable bowel syndrome. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinica chimica acta; international journal of clinical chemistry">Clin Chim Acta 2009 Feb 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19361459/abstract/Role_of_serotonin_in_gastrointestinal_motility_and_irritable_bowel_syndrome_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19361459/full_citation/Role_of_serotonin_in_gastrointestinal_motility_and_irritable_bowel_syndrome_">Full Citation</a></description></item><item><title>Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19086332/full_citation/Neural_and_psychological_predictors_of_treatment_response_in_irritable_bowel_syndrome_patients_with_a_5_HT3_receptor_antagonist:_a_pilot_study_</link><description>Jarcho JM, Chang L, Berman M, et al. <br/><span class="title">Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Alimentary pharmacology &amp; therapeutics">Aliment Pharmacol Ther 2008 Aug 1; 28(3):344-52.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19086332/abstract/Neural_and_psychological_predictors_of_treatment_response_in_irritable_bowel_syndrome_patients_with_a_5_HT3_receptor_antagonist:_a_pilot_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19086332/full_citation/Neural_and_psychological_predictors_of_treatment_response_in_irritable_bowel_syndrome_patients_with_a_5_HT3_receptor_antagonist:_a_pilot_study_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19086332/Neural_and_psychological_predictors_of_treatment_response_in_irritable_bowel_syndrome_patients_with_a_5_HT3_receptor_antagonist:_a_pilot_study_">Find Related Articles</a> </description></item></channel></rss>